BMRN
Price
$54.22
Change
-$1.10 (-1.99%)
Updated
Nov 13 closing price
Capitalization
10.42B
103 days until earnings call
Intraday BUY SELL Signals
COYA
Price
$5.96
Change
-$0.13 (-2.13%)
Updated
Nov 13 closing price
Capitalization
124.08M
Intraday BUY SELL Signals
Interact to see
Advertisement

BMRN vs COYA

Header iconBMRN vs COYA Comparison
Open Charts BMRN vs COYABanner chart's image
BioMarin Pharmaceutical
Price$54.22
Change-$1.10 (-1.99%)
Volume$2.26M
Capitalization10.42B
Coya Therapeutics
Price$5.96
Change-$0.13 (-2.13%)
Volume$211.23K
Capitalization124.08M
BMRN vs COYA Comparison Chart in %
BMRN
Daily Signal:
Gain/Loss:
COYA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BMRN vs. COYA commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and COYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BMRN: $54.22 vs. COYA: $5.96)
Brand notoriety: BMRN and COYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 92% vs. COYA: 112%
Market capitalization -- BMRN: $10.42B vs. COYA: $124.08M
BMRN [@Biotechnology] is valued at $10.42B. COYA’s [@Biotechnology] market capitalization is $124.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileCOYA’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • COYA’s FA Score: 0 green, 5 red.
According to our system of comparison, both BMRN and COYA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 4 TA indicator(s) are bullish while COYA’s TA Score has 2 bullish TA indicator(s).

  • BMRN’s TA Score: 4 bullish, 3 bearish.
  • COYA’s TA Score: 2 bullish, 9 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than COYA.

Price Growth

BMRN (@Biotechnology) experienced а +4.59% price change this week, while COYA (@Biotechnology) price change was +3.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

BMRN is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.4B) has a higher market cap than COYA($124M). COYA YTD gains are higher at: 6.283 vs. BMRN (-17.511). BMRN has higher annual earnings (EBITDA): 934M vs. COYA (-22.59M). BMRN has more cash in the bank: 1.43B vs. COYA (29.8M). BMRN has higher revenues than COYA: BMRN (3.06B) vs COYA (423K).
BMRNCOYABMRN / COYA
Capitalization10.4B124M8,387%
EBITDA934M-22.59M-4,134%
Gain YTD-17.5116.283-279%
P/E Ratio20.16N/A-
Revenue3.06B423K724,350%
Total Cash1.43B29.8M4,805%
Total Debt604MN/A-
FUNDAMENTALS RATINGS
BMRN: Fundamental Ratings
BMRN
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
64
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMRNCOYA
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
53%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
89%
Declines
ODDS (%)
Bearish Trend 8 days ago
62%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signal:
Gain/Loss:
COYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POSC1.610.06
+4.02%
Positron Corp.
SUTNY5.850.16
+2.81%
Sumitomo Mitsui Trust Group, Inc.
BFLBF121.40N/A
N/A
Bilfinger SE
CALZF0.79N/A
N/A
Polynovo Ltd.
RAFA0.04N/A
N/A
Rafarma Pharmaceuticals, Inc. (WY)

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with TECH. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-1.99%
TECH - BMRN
55%
Loosely correlated
-1.06%
SYRE - BMRN
46%
Loosely correlated
-3.41%
BEAM - BMRN
46%
Loosely correlated
-0.96%
IRON - BMRN
46%
Loosely correlated
+1.19%
JAZZ - BMRN
45%
Loosely correlated
+3.66%
More

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with GANX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then GANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
+1.33%
GANX - COYA
42%
Loosely correlated
+10.07%
KNSA - COYA
42%
Loosely correlated
+0.02%
ATXS - COYA
38%
Loosely correlated
+0.32%
BMRN - COYA
34%
Loosely correlated
+0.71%
TRDA - COYA
32%
Poorly correlated
+4.03%
More